Back to search results

Ketamine for Methamphetamine Use Disorder

Abroad (travel likely)RecruitingPHASE2

Conditions

Substance Use Disorders · Substance Use · Methamphetamine Abuse

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Alameda Health System, San Leandro, California, United States

    Contact: Study coordinator (Stephanie Gallardo, BA) · stgallardo@alamedahealthsystem.org · 510-495-4643
    Contact: Study coordinator (Bridge Clinic) · 510-545-2765
    Contact: Principal Investigator (Erik Anderson, MD)

  • Interdisciplinary Substance Use and Brain Injury Facility, Albuquerque, New Mexico, United States

  • Addiction Institute of Mount Sinai, New York, New York, United States

  • Prisma Health, Greenville, South Carolina, United States

    Sarah · sarah.feingold@prismahealth.org · 864-960-3183
    Anthony · Anthony.Faso@prismahealth.org · 864-735-8682
    Contact: Principal Investigator (Alain Litwin, MD)

  • UT Southwestern Medical Center, Dallas, Texas, United States

Study leads

  • Madhukar Trivedi, MD

    Principal Investigator

    Professor (Tenured)

View source on ClinicalTrials.gov(opens in a new tab)